MR-guided linac boost for gynecologic cancers when brachytherapy isn’t possible
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a targeted radiation “boost” delivered using an MRI-guided machine for certain gynecologic cancers when the usual treatment (brachytherapy) can’t be done. It may help improve control of the cancer while still aiming for cure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or recurrent gynecologic cancer (not ovarian cancer), or endometrial cancer, and your doctors plan curative (chemo)radiation.
- If your cancer has spread to lymph nodes in the belly area, it must be limited to the level of L2 (not further spread).
- Your cancer stage must match standard staging systems your care team can confirm (FIGO/TNM).
- You must have already consented for your clinical data to be used for a related study called MOMENTUM (NCT04075305).
- You must be able to safely have an MRI scan (no hard contraindications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses MRI scans during chemoradiation to improve treatment accuracy for cervical cancer. It may help patients who need standard chemoradiation plus brachytherapy.
This feasibility study tests whether an MRI-guided radiation approach can be used safely and practically for people with certain stages of cervical cancer. It’s meant to help doctors plan radiation more accurately, while checking whether the treatment process works well.
This study follows what happens when radiation treatment is guided using an MR-Linac (a special machine that combines MRI imaging with radiation). It may help improve how radiation therapy is planned and assessed, especially for people who can safely have MRI scans.
This trial tests adding an extra, targeted radiation dose directly into the tumor for women with bulky cervical cancer, alongside standard chemoradiation. It aims to improve local control without increasing side effects.
This trial tests a more precise way to deliver radiation for locally advanced cervical cancer using MRI guidance during treatment, along with chemotherapy. It may help shrink tumors more effectively while aiming to reduce side effects by targeting the right areas.
This trial tests a new way to deliver radiation therapy to endometrial cancer patients after surgery, using MRI scans to precisely target the treatment area. The goal is to improve accuracy while potentially reducing side effects.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.